November 5, 2019
SCOR Global Life has made a strategic investment in BioSerenity, a French medical solutions company that aims to optimize the patient pathways in several chronic diseases through the design of connected devices, end-t
November 5, 2019
SCOR Global Life has made a strategic investment in BioSerenity, a French medical solutions company that aims to optimize the patient pathways in several chronic diseases through the design of connected devices, end-t
This publication presents some global information on kidney diseases, the definitions and basic notions, protective treatments, renal replacement therapies, disease progression information as well as proposed underwri
October 30, 2019
A weather analysis of China’s agricultural production risk
October 28, 2019
In order to achieve the objectives of the “Quantum Leap” strategic plan, SCOR Global Life evolves its organisation and announces promotions in its Global Markets team.
First Nine Months 2019 Results
First Nine Months 2019 Results
SCOR delivers a solid performance with net income of EUR 401 million in the first nine months of 2019
October 23, 2019
The theme of SCOR's 2019 Annual Conference was "The Acceleration of Hubs, Networks and Connectivity: How to ensure the sustainability of insurability and its development".
A weather analysis of China’s agricultural production risk.
Legal information
SOLEM supports our clients throughout the world to assess risks, including a dedicated Claims management section.
Pagination